Activity of recombinant factor VIIa under different conditions in vitro: Effect of temperature, pH, and haemodilution

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 5, 2008, Pages 369-374

  Bladbjerg, Else Marie ^a,b   Jespersen, Jørgen ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Haemodilution; In vitro; pH; Recombinant activated factor VII; Rotational thromboelastometry; Temperature

Indexed keywords

BLOOD CLOTTING FACTOR 7; DEXTRAN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT THROMBOPLASTIN; RFVIIA; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; BODY TEMPERATURE; FIBRINOLYSIS; HEMODILUTION; HUMAN; IN VITRO STUDY; LOW TEMPERATURE; PH MEASUREMENT; PRIORITY JOURNAL; ROTATIONAL THROMBOELASTOMETRY; TEMPERATURE MEASUREMENT; THROMBOELASTOGRAPHY;

FACTOR VIIA; HEMODILUTION; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY; TIME FACTORS;

EID: 62549100762     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328304b602     Document Type: Article

References (30)

1. Hedner U, Kisiel W. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest 1983; 71:1836-1841.
2. Hedner U. Recombinant FVIIa. Vox Sang 2004; 87:25-28.
3. Franchini M. Recombinant factor VIIa: a review on its clinical use. Int J Hematol 2006; 83:126-138.
4. Hedner U. Recombinant factor VIIa: its background, development and clinical use. Curr Opin Hematol 2007; 14:225-229.
5. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99:923-930.
6. Butenas S, Brummel KE, Paradis SG, Mann KG. Influence of factor VIIa and phospholipids on coagulation in 'acquired' hemophilia. Arterioscler Thromb Vasc Biol 2003; 23:123-129.
7. Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 1998; 9:15-20.
8. Gabriel DA, Li X, Monroe DM, Roberts HR. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2004; 2:1816-1822.
9. Lisman T, De Groot G. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003; 1:1138-1139.
10. Hedner U. Mechanism of action, development and clinical experience of recombinant FVIIa. J Biotechnol 2006; 124:747-757.
11. Rose L. Recombinant factor VIIa: review of current 'off license' indications and implications for practice. AACN Adv Crit Care 2007; 18:141- 148.
12. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354:1879.
13. Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 2002; 49:S15-S20.
14. Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-15.
15. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002; 28:241-247.
16. Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55:886-891.
17. Valeri CR, Feingold H, Cassidy G, Rango G, Khuri S, Altschule MD. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987; 205:175-181.
18. Wolberg AS, Meng ZH, Monroe DM, Hoffman M.A systematic evaluation of the effect of temperature on coagulations enzyme activity and platelet function. J Trauma 2004; 56:1221-1228.
19. Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001; 50:721-729.
20. Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Nacaitis JM, Hoots K. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. J Trauma 2002; 53:252-259.
21. Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study. J Thromb Haemost 2007; 5:244-249.
22. Mortier E, Ongenae M, De Baerdemaeker L, Herregods L, Den Bauwen N, Van Aken J, et al. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 1997; 52:1061-1064.
23. De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29:1261-1267.
24. Fenger-Eriksen C, Anker-Møller E, Heslop J, Ingerslev J, Sørensen B. Thromboelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94:324-329.
25. Stogermuller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91:823-827.
26. De Jonge E, Levi M, Buller HR, Berends F, Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of rapidly degradable hydroxyethyl starch (HES200/0.5/6) in healthy human subjects. Intensive Care Med 2001; 27:1825-1829.
27. Soerensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thromboelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1:551-558.
28. Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005; 3:640-648.
29. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, et al. Citrate storage affects thromboelastograph analysis. Anesthesiology 2000; 92:1242-1249.
30. LuddingtonRJ. Thromboelastography/thromboelastometry. Clin Lab Haem 2005; 27:81-90.